Genetic variability at the human FMO1 locus:: Significance of a basal promoter Yin Yang 1 element polymorphism (FMO1*6)

被引:32
作者
Hines, RN
Luo, ZH
Hopp, KA
Cabacungan, ET
Koukouritaki, SB
McCarver, DG
机构
[1] Med Coll Wisconsin, Dept Pediat, Birth Defects Res Ctr, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Pharmacol Toxicol, Milwaukee, WI 53226 USA
关键词
D O I
10.1124/jpet.103.053686
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The flavin-containing monooxygenases (FMOs) are important for the disposition of a variety of toxicants, therapeutics, and dietary components. Although FMO1 is the dominant isoform in fetal liver and adult kidney and intestine and despite up to a 10-fold intersubject variation in expression, a paucity of information is available on FMO1 genetic variability. To address this issue, 24 samples from the Coriell DNA Polymorphism Discovery Resource Panel were sequenced revealing 10 common single nucleotide polymorphisms (SNPs): four located upstream of the structural gene; three within exonic sequences; one within the intron 1 splice donor site; and two with the 3'-untranslated region. Six of these variants are novel. Compared with other FMO loci within the chromosome 1q23-25 cluster, FMO1 seems more highly conserved. Of the identified FMO1 SNPs, only a C>A transversion 9,536 base pairs upstream of the exon 2 ATG start codon (g.-9,536C>A) would likely affect function, because it lies within the conserved core binding sequence for the yin yang 1 (YY1) transcription factor. Electrophoretic mobility shift assays demonstrated that the g.-9,536C>A transversion eliminated YY1 binding. Furthermore, data from transient expression assays in HepG2 cells suggested this SNP could account for a 2- to 3-fold loss of FMO1 promoter activity. Genotype analysis revealed a g.-9,536A allele (FMO1*6) frequency of 13 and 11% in African- and northern European-Americans, respectively, but a significantly higher frequency of 30% in Hispanic-Americans. Thus, the FMO1*6 variant may account for some of the observed interindividual variation in FMO1 expression.
引用
收藏
页码:1210 / 1218
页数:9
相关论文
共 40 条
[1]  
BOUCHER PD, 1993, J BIOL CHEM, V268, P17384
[2]  
CASHMAN JR, 1993, DRUG METAB DISPOS, V21, P587
[3]  
Cashman JR, 2001, DRUG METAB DISPOS, V29, P1629
[4]   TERTIARY-AMINES RELATED TO BROMPHENIRAMINE - PREFERRED CONFORMATIONS FOR N-OXYGENATION BY THE HOG LIVER FLAVIN-CONTAINING MONOOXYGENASE [J].
CASHMAN, JR ;
CELESTIAL, JR ;
LEACH, A ;
NEWDOLL, J ;
PARK, SB .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1097-1105
[5]  
CASHMAN JR, 2002, ENZYME SYSTEMS METAB, P67
[6]  
CLEMENT B, 1993, DRUG METAB DISPOS, V21, P24
[7]   A DNA polymorphism discovery resource for research on human genetic variation [J].
Collins, FS ;
Brooks, LD ;
Chakravarti, A .
GENOME RESEARCH, 1998, 8 (12) :1229-1231
[8]   Nomenclature for the description of human sequence variations [J].
den Dunnen, JT ;
Antonarakis, E .
HUMAN GENETICS, 2001, 109 (01) :121-124
[9]  
Donohoe ME, 1999, MOL CELL BIOL, V19, P7237
[10]   Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans [J].
Furnes, B ;
Feng, JN ;
Sommer, SS ;
Schlenk, D .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (02) :187-193